These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4059296)

  • 1. Dose-finding clinical assay of triletide in gastric and duodenal ulceration.
    Waucquez JL
    Pharmatherapeutica; 1985; 4(3 Spec No):146-54. PubMed ID: 4059296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled clinical assessment of the efficacy and tolerance of triletide versus antacids in patients with gastric and duodenal ulcers.
    Hoetzinger H
    Pharmatherapeutica; 1985; 4(3 Spec No):155-60. PubMed ID: 3903784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoprotective approach to peptic ulcer therapy: a preliminary dose-finding clinical investigation with triletide.
    Maggi CA; Ferrari D
    Pharmatherapeutica; 1985; 4(3 Spec No):141-5. PubMed ID: 4059295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoprotective therapy of gastric ulcers: a controlled clinical evaluation of triletide versus carbenoxolone.
    Campisi D; Cataldo MG; Paterna S; Bivona A; Barbarino C
    Pharmatherapeutica; 1985; 4(3 Spec No):166-70. PubMed ID: 3903785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of triletide versus antacids in the treatment of duodenal ulcer out-patients.
    Trabucchi E; Longoni F; Baratti C; Boccasanta P
    Pharmatherapeutica; 1985; 4(3 Spec No):161-5. PubMed ID: 4059297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triletide in a cimetidine-controlled clinical evaluation in duodenal ulcer patients.
    Primbs P
    Pharmatherapeutica; 1985; 4(3 Spec No):177-81. PubMed ID: 3903786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combined treatment with triletide and cimetidine in gastric and duodenal ulcer patients, and a retrospective comparison with cimetidine alone.
    d'Ambrosio G; d'Annabile A
    Pharmatherapeutica; 1985; 4(3 Spec No):171-6. PubMed ID: 4059298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triletide and ranitidine for the management of chronic duodenal ulcer: a controlled clinical investigation.
    Gandolfi L; Solmi L
    Pharmatherapeutica; 1985; 4(3 Spec No):182-8. PubMed ID: 3903787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
    Ramón Nogueira J; Esquivel Ayanegui F; Esquivel Rodríguez F; Sáenz V; Santoyo R
    Rev Gastroenterol Mex; 1996; 61(4):314-9. PubMed ID: 9072782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of sucralfate and cimetidine in the treatment of duodenal and gastric ulcers. A multicenter study.
    Pop P; Nikkels RE; Thys O; Dorrestein GC
    Scand J Gastroenterol Suppl; 1983; 83():43-7. PubMed ID: 6356320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirenzepine (LS 519) in severe duodenal ulcer and in gastric ulcer. A double-blind clinical trial.
    Oselladore D; Chierichetti SM; Norberto L; Vibelli C
    Scand J Gastroenterol Suppl; 1979; 57():33-9. PubMed ID: 396655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is 1-week treatment for peptic ulcer healing sufficient and safe?
    García S; Fuentes J; Ducóns JA; Barrera F; Yus C; Gomollón F
    Rev Esp Enferm Dig; 2000 Jan; 92(1):5-12. PubMed ID: 10749593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled comparison of sucralfate and cimetidine in duodenal ulcer.
    Hentschel E; Schütze K; Dufek W
    Scand J Gastroenterol Suppl; 1983; 83():31-5. PubMed ID: 6356318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric and duodenal ulcer healing under placebo treatment.
    Scheurer U; Witzel L; Halter F; Keller HM; Huber R; Galeazzi R
    Gastroenterology; 1977 May; 72(5 Pt 1):838-41. PubMed ID: 849813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of duodenal and gastric ulcer with ranitidine--a controlled, multicentre clinical trial.
    Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):64-9. PubMed ID: 6286274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
    Marks IN; Lucke W; Wright JP; Girdwood AH
    J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healing of duodenal ulcer with an antacid regimen.
    Peterson WL; Sturdevant RA; Frankl HD; Richardson CT; Isenberg JI; Elashoff JD; Sones JQ; Gross RA; McCallum RW; Fordtran JS
    N Engl J Med; 1977 Aug; 297(7):341-5. PubMed ID: 876324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirenzepine in duodenal ulcer. A six week, double-blind study.
    Do D; Martelli S; Daniotti S
    Scand J Gastroenterol Suppl; 1982; 72():211-4. PubMed ID: 6753115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sucralfate effervescent tablet: treatment of peptic ulcer disease and change in serum aluminium concentration.
    Schütze K; Hentschel E; Happonen P; Akkila J
    Hepatogastroenterology; 1995 Jul; 42(3):240-5. PubMed ID: 7590572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
    Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
    Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.